Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone
about
Antimicrobial resistance among commensal isolates of Escherichia coli and Staphylococcus aureus in the Indonesian population inside and outside hospitals.Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance.Vancomycin-resistant enterococcal bacteremia in a hematology unit: molecular epidemiology and analysis of clinical course.Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY program, 1999 to 2001.VIM- and IMP-type metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals.Pyogenic and amebic liver abscesses.Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea.Drug utilization review of mupirocin ointment in a Korean university-affiliated hospital.Carbapenem-resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in Korea.Four Year Trend of Carbapenem-Resistance in Newly Opened ICUs of a University-Affiliated Hospital of South Korea.Phenotypic Detection of Extended Spectrum Beta lactamase and Carbapenemase Co-producing Clinical Isolates from Two Tertiary Hospitals in Kano, North West Nigeria.Mutations in the gyrA and parC genes in ciprofloxacin-resistant clinical isolates of Acinetobacter baumannii in Korea.
P2860
Q33302519-9482314A-CD79-4EA0-8B5A-42F16B80FC68Q33565503-BE3D90BE-9560-42B6-986A-2AC8BE0BEA51Q33599435-5953B818-47EA-4C93-AE51-56F5B4A713D5Q34139244-0ADBA1A4-41A7-4BA0-94C5-A110E48F3527Q34502934-4770F8F8-78FC-4BCD-9917-39CC748BD48CQ35831945-88389D94-6768-41E9-B499-CC9F46A6FCFBQ37485601-FC0F9E60-0C29-4651-93DE-E8491FC3FF77Q38544750-FFEABDED-D7F7-4F58-9996-8EB29886A7E6Q40530202-7F23D078-DA36-4DF9-9640-1FEC875086CCQ42073593-8463F5B7-C06C-4F7C-81C8-4B27B94E7CF3Q42235640-20AF0D48-F7B5-4830-8413-1FB86EAD3D25Q46610974-686CEAEA-B12F-4F1C-815D-6CB5F778988A
P2860
Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antimicrobial resistance surve ...... imipenem, and fluoroquinolone
@ast
Antimicrobial resistance surve ...... imipenem, and fluoroquinolone
@en
Antimicrobial resistance surve ...... imipenem, and fluoroquinolone
@nl
type
label
Antimicrobial resistance surve ...... imipenem, and fluoroquinolone
@ast
Antimicrobial resistance surve ...... imipenem, and fluoroquinolone
@en
Antimicrobial resistance surve ...... imipenem, and fluoroquinolone
@nl
prefLabel
Antimicrobial resistance surve ...... imipenem, and fluoroquinolone
@ast
Antimicrobial resistance surve ...... imipenem, and fluoroquinolone
@en
Antimicrobial resistance surve ...... imipenem, and fluoroquinolone
@nl
P2093
P921
P3181
P1476
Antimicrobial resistance surve ...... imipenem, and fluoroquinolone
@en
P2093
P304
P3181
P356
10.3346/JKMS.2001.16.3.262
P407
P577
2001-06-01T00:00:00Z